Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50110183 (ABEMACICLIB | Abemaciclib | LY-2835219 | US1066218...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | Purchase PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448933 (N-(5-(4-Aminopiperidine-1-yl)pyridin-2-yl)-5-fluor...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448924 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 86.6 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448979 (N-(5-(3,5-Dimethylpiperazin-1-yl)pyridin-2-yl)-5-f...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 94.8 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448930 (4-(1,1-Dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 109 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448945 ((R)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448962 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448944 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448944 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448944 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 241 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448945 ((R)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 275 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448979 (N-(5-(3,5-Dimethylpiperazin-1-yl)pyridin-2-yl)-5-f...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448948 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448947 (2-(4-(6-((5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-di...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448936 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 351 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455057 (CHEMBL4215702 | US10696678, Example 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 354 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448940 (N-(5-(4-Ethylpiperazin-1-yl)pyridin-2-yl)-5-fluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 376 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448924 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448962 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 481 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448951 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448945 ((R)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448930 (4-(1,1-Dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448932 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448979 (N-(5-(3,5-Dimethylpiperazin-1-yl)pyridin-2-yl)-5-f...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455061 (CHEMBL4211828 | US10696678, Example 65) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455051 (CHEMBL4210028 | US10696678, Example 24) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448977 (4-(5-Fluoro-1-methyl-2,3-dihydro-1H-benzo[d]pyrrol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 693 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448948 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 732 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448935 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 744 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448952 ((S)—N-(5-((3,4-Dimethylpiperazin-1-yl)methyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 745 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455057 (CHEMBL4215702 | US10696678, Example 20) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448947 (2-(4-(6-((5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-di...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455050 (CHEMBL4208172 | US10696678, Example 18) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448947 (2-(4-(6-((5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 959 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455068 (CHEMBL4205645 | US10696678, Example 22) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448976 (N-(5-(4-(Dimethylamino)piperidine-1-yl)pyridin-2-y...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448964 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448935 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448922 (5-Fluoro-4-(4-fluoro-7,8,9,10-tetrahydro-6H-benzo[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448932 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448958 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448933 (N-(5-(4-Aminopiperidine-1-yl)pyridin-2-yl)-5-fluor...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455048 (CHEMBL4210707 | US10696678, Example 36) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448951 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448967 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455051 (CHEMBL4210028 | US10696678, Example 24) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50110183 (ABEMACICLIB | Abemaciclib | LY-2835219 | US1066218...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | Purchase PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448946 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.73E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448958 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448922 (5-Fluoro-4-(4-fluoro-7,8,9,10-tetrahydro-6H-benzo[...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455064 (CHEMBL4211479 | US10696678, Example 37) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448936 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455066 (CHEMBL4212542 | US10696678, Example 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448952 ((S)—N-(5-((3,4-Dimethylpiperazin-1-yl)methyl)...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455074 (CHEMBL4217694 | US10696678, Example 67) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455050 (CHEMBL4208172 | US10696678, Example 18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448933 (N-(5-(4-Aminopiperidine-1-yl)pyridin-2-yl)-5-fluor...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448930 (4-(1,1-Dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448952 ((S)—N-(5-((3,4-Dimethylpiperazin-1-yl)methyl)...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448931 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM50455061 (CHEMBL4211828 | US10696678, Example 65) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448938 (N-(5-((1-Ethylpiperidine-4-yl)oxy)pyridin-2-yl)-5-...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448958 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448932 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448939 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448966 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448939 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448960 (5-Fluoro-4-(5-fluoro-2,2-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455057 (CHEMBL4215702 | US10696678, Example 20) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448924 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448962 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448971 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448940 (N-(5-(4-Ethylpiperazin-1-yl)pyridin-2-yl)-5-fluoro...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 5.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455048 (CHEMBL4210707 | US10696678, Example 36) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455049 (CHEMBL4209318 | US10696678, Example 63) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448973 (4-(1-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cyclin-Dependent Kinase 1 (CDK1) (Homo sapiens (Human)) | BDBM448960 (5-Fluoro-4-(5-fluoro-2,2-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455058 (CHEMBL4208366 | US10696678, Example 14) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448940 (N-(5-(4-Ethylpiperazin-1-yl)pyridin-2-yl)-5-fluoro...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448950 (N-(5-(1-Ethylpiperidine-4-yl)pyridin-2-yl)-5-fluor...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 7.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455050 (CHEMBL4208172 | US10696678, Example 18) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448938 (N-(5-((1-Ethylpiperidine-4-yl)oxy)pyridin-2-yl)-5-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50110183 (ABEMACICLIB | Abemaciclib | LY-2835219 | US1066218...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | Purchase PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair |  3D Structure (crystal) | ||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448951 ((S)-5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 8.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448964 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448973 (4-(1-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448959 (4-(1-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455054 (CHEMBL4207451 | US10696678, Example 48) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448977 (4-(5-Fluoro-1-methyl-2,3-dihydro-1H-benzo[d]pyrrol...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455048 (CHEMBL4210707 | US10696678, Example 36) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.12E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448935 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.22E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455061 (CHEMBL4211828 | US10696678, Example 65) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448937 ((4-Ethylpiperazin-1-yl)(6-((5-fluoro-4-(5-fluoro-1...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448948 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448976 (N-(5-(4-(Dimethylamino)piperidine-1-yl)pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455060 (CHEMBL4213847 | US10696678, Example 70) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448949 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.45E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455051 (CHEMBL4210028 | US10696678, Example 24) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455053 (CHEMBL4215568 | US10696678, Example 49) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448977 (4-(5-Fluoro-1-methyl-2,3-dihydro-1H-benzo[d]pyrrol...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448949 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455064 (CHEMBL4211479 | US10696678, Example 37) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455068 (CHEMBL4205645 | US10696678, Example 22) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455067 (CHEMBL4207966 | US10696678, Example 73) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448926 (1-(2-((5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihyd...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448955 (5-Fluoro-4-(5-fluoro-2-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448918 (5-Fluoro-4-(6-fluoro-1,2,3,4-tetrahydrobenzo[4,5]i...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455059 (CHEMBL4214566 | US10696678, Example 12) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448960 (5-Fluoro-4-(5-fluoro-2,2-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.87E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448934 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.87E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448959 (4-(1-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455054 (CHEMBL4207451 | US10696678, Example 48) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448964 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455062 (CHEMBL4207804 | US10696678, Example 56) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448971 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448950 (N-(5-(1-Ethylpiperidine-4-yl)pyridin-2-yl)-5-fluor...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.17E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455060 (CHEMBL4213847 | US10696678, Example 70) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448974 (N-(5-(1-Ethylpiperidine-4-yl)pyridin-2-yl)-5-fluor...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.44E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455073 (CHEMBL4216447 | US10696678, Example 38) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455066 (CHEMBL4212542 | US10696678, Example 60) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448920 (1-(2-((5-Fluoro-4-(6-fluoro-1,2,3,4-tetrahydrobenz...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455066 (CHEMBL4212542 | US10696678, Example 60) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448963 (1-(2-((5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448946 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.85E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448967 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455062 (CHEMBL4207804 | US10696678, Example 56) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455052 (CHEMBL4215126 | US10696678, Example 64) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448974 (N-(5-(1-Ethylpiperidine-4-yl)pyridin-2-yl)-5-fluor...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455058 (CHEMBL4208366 | US10696678, Example 14) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.56E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455064 (CHEMBL4211479 | US10696678, Example 37) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448963 (1-(2-((5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.73E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448937 ((4-Ethylpiperazin-1-yl)(6-((5-fluoro-4-(5-fluoro-1...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455063 (CHEMBL4213109 | US10696678, Example 51) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.97E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448936 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448946 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 5.78E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448957 (4-(2-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.07E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448918 (5-Fluoro-4-(6-fluoro-1,2,3,4-tetrahydrobenzo[4,5]i...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448920 (1-(2-((5-Fluoro-4-(6-fluoro-1,2,3,4-tetrahydrobenz...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6.86E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448966 (5-Fluoro-4-(5-fluoro-1-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448931 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 8.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448934 (5-Fluoro-4-(5-fluoro-1,1-dimethyl-2,3-dihydro-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 8.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448928 (4-(5-Fluoro-1,1-dimethyl-2,3-dihydro-1H-benzo[d]py...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 9.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448957 (4-(2-Ethyl-5-fluoro-2,3-dihydro-1H-benzo[d]pyrrolo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.44E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM50455065 (CHEMBL4204961 | US10696678, Example 16) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.47E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455052 (CHEMBL4215126 | US10696678, Example 64) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.78E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK4/Cyclin D3 (Homo sapiens (Human)) | BDBM448922 (5-Fluoro-4-(4-fluoro-7,8,9,10-tetrahydro-6H-benzo[...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.36E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455059 (CHEMBL4214566 | US10696678, Example 12) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.44E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455065 (CHEMBL4204961 | US10696678, Example 16) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.48E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455073 (CHEMBL4216447 | US10696678, Example 38) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.71E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455049 (CHEMBL4209318 | US10696678, Example 63) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.75E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455063 (CHEMBL4213109 | US10696678, Example 51) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.39E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM448955 (5-Fluoro-4-(5-fluoro-2-methyl-2,3-dihydro-1H-benzo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 3.68E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455053 (CHEMBL4215568 | US10696678, Example 49) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.92E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| CDK6/CycD3 (Homo sapiens (Human)) | BDBM50455067 (CHEMBL4207966 | US10696678, Example 73) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.52E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GAN & LEE PHARMACEUTICALS US Patent | Assay Description In vitro inhibition of CDK (CDK1, CDK4, CDK6) activity by compounds of the present invention was tested by the following method.1. Preparation of kin... | US Patent US10696678 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
